BIO issues white paper on comparative effectiveness

Article

In a new paper, the Biotechnology Industry Organization reveals it has reservations about the use of comparative effectiveness in reviewing products.

The Biotechnology Industry Organization has issued a white paper on comparative effectiveness. Authored by BIO's director of economic policy Ted Buckley, Ph.D., the document maintains that while comparative effectiveness is a helpful tool for healthcare decision-makers when comparing different products, it cannot be used to provide one-size-fits-all answers. The report can be found on

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.